Preprint
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial
Abstract
Abstract
The efficacy of convalescent plasma for COVID-19 is unclear. While most randomized controlled trials have shown negative results, uncontrolled studies have suggested that the antibody content may influence patient outcomes.
Authors
Group TCS; committee CW; Bégin P; Callum J; Jamula E; Cook R; Heddle NM; Tinmouth A; Zeller MP; Beaudoin-Bussières G
DOI
10.1101/2021.06.29.21259427
Preprint server
medRxiv